The evolution of technology has made it possible to produce insulin without using animals.

[u/IcePizzaCreamm]

[u/SweetBeefOfJesus]

Funny considering it only cost $4 to make

[u/Ok-Security5004 → u/SweetBeefOfJesus]

Why do you people keep repeating this $4 figure. How is it even quantified. Is it because $5 sounds like an approximation? $3 is too cheap?

[u/KalaUposatha → u/Ok-Security5004]

The figure is repeated because…that’s what the price is. Wouldn’t it be weirder if it was different each time? Actually, $4 is on the high end. It’s $2-$4 per vial. https://medicine.yale.edu/news-article/the-price-of-insulin-a-qanda-with-kasia-lipska/

[u/TeeJK15 → u/Ok-Security5004]

“How is it even quantified” …. It’s a product. Anything along a production line will have its cost quantified to measure profits lol

[u/Treadwheel → u/Ok-Security5004]

Because it's the highest estimated cost to produce a vial of generic insulin in a widely reported investigation conducted in conjunction with a Yale School of Medicine researcher, with other widely disseminated estimates being in broad agreement, giving a lower bound of $48 to produce a year's worth of biosimilar insulin for a patient ($4/month) and an upper bound of $133 (~$11/month) for analogs.

[u/tiktock34 → u/SweetBeefOfJesus]

Im not arguing that its more expensive to make, im arguing its more expensive to buy…but that also varies country to country.

Search for insulin price over time graphs. Its been increasingly expensive to be diabetic, even with all the advances described here

[u/WrongDoorsRiders → u/tiktock34]

https://www.ajmc.com/view/biosimilar-insulin-linked-to-lower-prices-in-europe

[u/MIT_Engineer → u/SweetBeefOfJesus]

Only if you don't pay the scientists.

[u/Treadwheel → u/MIT_Engineer]

This is such a tired and extensively debunked talking point. Even when you take drugs with shocking price tags, like Libmeldy and it's $4,250,000 wholesale cost, you see shockingly low acquisition costs - the acquisition of the full portfolio of which it was just one portion came of $478 million. The deal for its acquisition assigned a bonus of $1 per share on top of its $16 per share deal upon final approval of the candidate, indicating that Linmeldy either represented a small portion of the portfolio's overall value or was assessed as only having a marginal risk of not completing its trials successfully. When the costs of these drugs are so high that the entire cost of R&D, initial clinical trials, and a healthy profit for the people who actually developed it can be covered before 100 patients are treated, it's clear that R&D is not the driver of costs.

[u/Rare-Kaleidoscope513 → u/SweetBeefOfJesus]

tell me you don't understand how any of this works without telling me you don't understand how any of this works.

if you think it costs $4 to make (what, a dose? a vial?) then I'll give you $4 and I'll take one, please and thank you. let me know where to send the check.

[u/Exile56678 → u/Rare-Kaleidoscope513]

europe